3 Healthcare Stocks I'd Buy Right Now
Illumina, Teladoc Health, and Vertex Pharmaceuticals enjoy strong competitive advantages and great growth opportunities.
Illumina
ILMN
ILMN
$347.85
-$3.26
-0.9%
BATS BZX Real Time Price as of June 18, 2019, 4:30 p.m.
View Interactive ILMN Charts
Illumina is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
News & Analysis: Illumina
The Fool has written over 400 articles on Illumina.
Top 5 Stocks in the Fight Against Cancer
These stocks are leading the way in their respective areas in battling cancer.
3 Cancer Treatment Stocks to Buy Right Now
These companies could make a big difference in how the disease is diagnosed and treated. And their stocks could make a big difference for long-term investors.
3 Top Healthcare Stocks to Buy Right Now
These stocks are bargains.
3 Healthcare Stocks I'd Buy Right Now
They're leaders in their markets. And those markets should grow tremendously.
3 Stocks to Buy and Hold for Decades
These companies focused on genetics, glamor, and gaming are worth considering for the long haul.
Where Will Illumina Be in 10 Years?
The gene sequencing pioneer could face several scenarios in the future -- from very good to very bad.
5 Top Stocks to Buy in May
Find out why this team of Motley Fool contributors believe these businesses are strong buys right now.
Illumina Inc (ILMN) Q1 2019 Earnings Call Transcript
ILMN earnings call for the period ending March 31, 2019.
Illumina Hits a Lull in the First Quarter
The gene-sequencing leader's revenue and earnings growth rates slowed down in the first quarter, but stronger growth is likely on the way.
